vialaudit

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

Amino Asylum logo
VENDOR AUDIT·PUBLIC DATA·UPDATED 2026-03-28

Amino Asylum

ships unknown3 peptides indexedpublic-data auditSHUTDOWN

Permanently shut down June 2025 following an FDA raid. Do not order.

0
OF 100
COMPOSITE — BELOW THRESHOLD
weighted across 4 facets

Score breakdown

40%
Purity
0/100
Composite of HPLC/MS chromatograms reviewed across mirrored COAs and any first-hand tests. Higher means cleaner peaks and fewer truncated-peptide artefacts.
25%
Pricing
0/100
Price per milligram against the median for the same compound and vial size across the vendors we track, at the sale price on the day we read the shop.
20%
Shipping & receipt
0/100
Stated processing and transit times, shipping policy, and the broader user-reported record. No first-hand order unless the page says so.
15%
Customer service
0/100
Published contact channels, refund and returns terms, operator transparency, and the user-reported record. No support test of ours unless the page says so.

Strengths & weaknesses

+ STRENGTHS
  • Historical: largest catalog in the grey-market segment
  • Historical: aggressive pricing
  • Historical: loyalty program with frequent sales
− WEAKNESSES
  • Permanently offline since June 2025 — payments cut, orders frozen
  • SARMs labeled products were found to contain testosterone (controlled substance)
  • COA practices were inconsistent across product lines

What it sells

3 PEPTIDES WE COVER

Shipping & payment

FROM PUBLISHED POLICY AND USER REPORTS
DOMESTIC SHIPPING · STATED
0.0d
PAYMENT
cryptocard
LAST REVIEWED
2026-03-28

Audit notes

FROM THE BENCH

What happened

In June 2025 the FDA conducted a raid on Amino Asylum. The company went permanently offline within hours: payment processing was cut, the website returned a server error, and thousands of pending orders were never shipped. There was no customer notice.

The federal charges that triggered the raid concerned products labeled as SARMs that, on testing, contained testosterone — a controlled substance. A parallel pattern of inconsistent COA practices across the broader catalog raises questions about quality control on peptides as well, though no formal peptide-specific charges were brought.

Scale before the shutdown

Pre-raid traffic estimates put Amino Asylum at 400,000+ monthly website visitors, making it one of the top five most-searched peptide vendors in the United States. The community impact of the closure was substantial: researchers who had relied on Amino Asylum's pricing and catalog depth discovered, often for the first time, the importance of independent COAs and third-party testing.

What this audit page exists for

We keep this page live for three reasons:

  1. Historical record. The methodology page commits to never quietly rewriting history. The Amino Asylum audit existed; it now reflects the vendor's terminal status.
  2. Reader signal. Search traffic still arrives via "is amino asylum still operating" and similar queries. Better that those readers land on accurate shutdown information than on a thirty-source aggregator.
  3. Editorial precedent. Vendor closures are now a recurring event in this market — Peptide Sciences (March 2026) and Paradigm Peptides (March 2024; pleas December 2025) followed the same pattern. We document them.

Where the catalog migrated

The displaced reader population has largely moved to: Limitless Biotech (formerly Limitless Life Nootropics) and Particle Peptides for the GLP-1 segment Amino Asylum dominated. Both have current public-data audit profiles on this site.

Other vendors we've audited

VIEW ALL →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH